SLC2A1 and invasive breast carcinoma: In a large series of invasive breast carcinomas, previously classified for molecular subtypes [27], immunohistochemistry staining was performed for P-cadherin, HIF-1α, GLUT1, CAIX, MCT1, MCT4, and CD147 (Figure 1).